Vivimed Labs Limited, headquartered in India, is a prominent player in the pharmaceutical and specialty chemicals industry. Founded in 1988, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Vivimed Labs focuses on the development and manufacturing of a diverse range of products, including active pharmaceutical ingredients (APIs), formulations, and advanced intermediates, which are distinguished by their high quality and innovative formulations. With a commitment to research and development, Vivimed Labs has achieved significant milestones, positioning itself as a trusted partner for global pharmaceutical companies. The company’s dedication to sustainability and regulatory compliance further enhances its reputation in the market. As a result, Vivimed Labs Limited continues to be recognised for its excellence and reliability in delivering cutting-edge solutions tailored to meet the evolving needs of the healthcare sector.
How does Vivimed Labs Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vivimed Labs Limited's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vivimed Labs Limited, headquartered in India, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their total emissions, including Scope 1, Scope 2, and Scope 3 emissions, are not provided. The company has not outlined any specific reduction targets or commitments related to climate initiatives, such as those from the Science Based Targets initiative (SBTi). Furthermore, there are no documented climate pledges or significant reduction initiatives reported at this time. As there is no emissions data or reduction commitments available, it is unclear how Vivimed Labs Limited is addressing its carbon footprint or contributing to climate action within the industry context.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vivimed Labs Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

